Latest filing published 21 Feb 2023 for Codiak BioSciences, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kyriazi Theo Melas discloses dealings in 4 companies, chiefly Codiak BioSciences, Inc., Bausch Health Companies Inc. and Kaleido Biosciences, Inc. The record holds 5 filings, for trades running from 31 December 2015 to 16 February 2023.
The open-market record is one-sided, with 2 purchases worth €305k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 1 option exercise.
The latest filing, published on 21 February 2023, reports an option exercise in Codiak BioSciences, Inc. The last insider purchase was made public on 30 April 2021, 2,002 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations